<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="3-part\PMC7108492\results\search\funders\results.xml">
  <result pre="Middle East Respiratory Syndrome coronavirus R&amp;amp;D research and development WHO" exact="World Health Organization" post="INTRODUCTION In recent decades, the world has been shaken"/>
  <result pre="and because the vesicular stomatitis virus–Ebola virus vaccine manufactured by" exact="Merck" post="demonstrated effectiveness in field trials (7). However, none of"/>
  <result pre="countries for epidemic responses (11). At the same time, the" exact="World Health Organization" post="(WHO) published its Blueprint priority diseases list for EID"/>
  <result pre="its mission, through the contributions of 7 government donors, the" exact="European Commission," post="and 2 philanthropic organizations. Three calls for proposals have"/>
  <result pre="stomatitis virus vector technology May 2018 Profectus Biosciences, Emergent, and" exact="PATH" post="$25 million to develop a recombinant subunit protein vaccine"/>
  <result pre="vaccine against Nipah virus May 2018 Profectus Biosciences, Emergent, and" exact="PATH" post="$36 million to develop an attenuated VesiculoVax vaccine against"/>
  <result pre="(including H1N1 influenza, rabies virus, and Marburg virus) December 2019" exact="University of Queensland" post="$10.6 million to develop a &quot;molecular clamp�? vaccine platform,"/>
  <result pre="(including influenza virus, MERS-CoV, and respiratory syncytial virus) December 2019" exact="University of Tokyo" post="$31 million to develop a vaccine against Nipah virus"/>
  <result pre="Rift Valley fever, using an attenuated virus technology July 2019" exact="Colorado State University" post="$9.5 million for manufacturing and preclinical studies to assess"/>
  <result pre="for Action to Prevent Epidemics: Plan of Action. Geneva, Switzerland:" exact="World Health Organization;" post="2016http://www.who.int/blueprint/about/r_d_blueprint_plan_of_action.pdf?ua=1. Accessed September 10, 2019. 9.collab: High-Level Panel on"/>
  <result pre="9.collab: High-Level Panel on Access to Health TechnologiesReport of the" exact="United Nations" post="Secretary-General’s High-Level Panel on Access to Medicines. Promoting Innovation"/>
  <result pre="Medicines. Promoting Innovation and Access to Health Technologies. Geneva, Switzerland:" exact="United Nations;" post="2016https://static1.squarespace.com/static/562094dee4b0d00c1a3ef761/t/57d9c6ebf5e231b2f02cd3d4/1473890031320/UNSG+HLP+Report+FINAL+12+Sept+2016.pdf. Accessed September 10, 2019. 10.GatesBThe next epidemic—lessons from"/>
  <result pre="World Health Organization2018 Annual Review of Diseases Prioritized Under the" exact="Research and Development" post="Blueprint: Geneva, Switzerland: World Health Organization; 2018http://www.who.int/emergencies/diseases/2018prioritization-report.pdf?ua=1. Accessed September"/>
  <result pre="Diseases Prioritized Under the Research and Development Blueprint: Geneva, Switzerland:" exact="World Health Organization;" post="2018http://www.who.int/emergencies/diseases/2018prioritization-report.pdf?ua=1. Accessed September 10, 2019. 13.GouglasD, HoytK, PeacockeESetting strategic"/>
 </snippets>
</snippetsTree>
